You are here: Industry Insights > Clinical Trial

News List

China approves clinical trials for 16 indigenous COVID-19 vaccines expresspharma
February 22, 2021
China has already given conditional approval to two inactivated COVID-19 vaccines made by state-owned developers -- Sinopharm and Sinovac Biotech.
AstraZeneca COVID-19 Vaccine Confirms 100% Protection Against Severe Disease in Phase III Trials americanpharmaceuticalreview
February 08, 2021
The primary analysis of the Phase III clinical trials from the UK, Brazil and South Africa, published as a preprint in The Lancet confirmed COVID-19 Vaccine AstraZeneca is safe and effective at preventing COVID-19, with no severe cases and no ...
AstraZeneca expects US trial results in next 4-6 weeks, research chief says expresspharma
February 08, 2021
Some experts had expected the data sooner than that, given the high infection rates in the United States during the period of testing.
TCAI physicians participate in clinical trial for potential life-saving device for patients with heart rhythm disorders prnasia
February 05, 2021
Physicians with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center are among the first in the world to participate in a clinical trial to evaluate a new esophageal protection device designed to make ablation procedures safer ...
Oxford Kept COVID-19 Vaccine Trial Volunteers in Dark About Dosing Error, Letter Shows expresspharma
February 04, 2021
The letter was signed by the trial’s chief investigator, Oxford professor Andrew J. Pollard, and sent to the trial subjects.
Jemincare initiates phase I clinical trial of anti-SARS-CoV-2 neutralizing antibody JMB2002 prnasia
January 20, 2021
On January 15, Jemincare Group, a Chinese pharmaceutical company, announced that it has initiated the phase I clinical trial of anti-SARS-CoV-2 neutralizing antibody (JMB2002).
Dr Reddy’s gets DCGI nod for Phase 3 clinical trial for Sputnik V vaccine expresspharma
January 18, 2021
The phase 3 study of Sputnik V will be conducted on 1500 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India.
Halt Bharat Biotech’s COVAXIN trial in Bhopal: Civil society organisations expresspharma
January 15, 2021
These organisations state that unethical conduct, protocol violations in a clinical trial where an apex government body is a co-sponsor is particularly alarming.
China NMPA Grants Approval for the Registrational Phase 1/2 Clinical Study for GC007g - an Allogeneic CAR-T Cell Therapy for the Treatment of Relapsed or Refractory B-ALL prnasia
January 14, 2021
Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, has been granted approval for a pivotal seamless Phase 1/2 clinical ...
Dr Reddy’s announces Sputnik V meets primary endpoint of safety in Phase 2 trial in India expresspharma
January 13, 2021
Dr Reddy’s submitted the phase 2 safety data for DCGI’s approval to continue phase 3 clinical trials.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page